Who Paid My Doc
Acp-204
Drug Alzheimers Disease Psychosis
General payments
$56,885
Research payments
$12,314,201
Through program year 2025, $56,885 in general payments and $12,314,201 in research payments were reported against Acp-204 (Alzheimers Disease Psychosis).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
4 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $55,385 | 17 |
| 2025 | Research | $9,648,708 | 2,618 |
| 2024 | General | $1,500 | 1 |
| 2024 | Research | $2,665,493 | 592 |
Breakdown
The top 5 of 10 recipients; each share is of general payments naming this product in 2025.
The top 5 of 6 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 8 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
18 general · 3,210 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.